Testosterone deprivation increases tendency to obesity but does not affect cardiac function in dogs
Main Article Content
Abstract
Low testosterone levels in humans is associated with increased risk of cardiovascular diseases (CVD). A previous study reported that low testosterone can induce left ventricular dysfunction and cardiac mitochondrial impairment as well as increase the risk of ischemic heart disease. The effect of testosterone deprivation on cardiac function in dogs, however, has never been investigated. The present study tested the hypothesis that testosterone deprivation induces impairment of cardiac function in healthy castrated male dogs. In this study, twenty-three healthy male dogs were divided into two groups: an intact group (n = 15) and a castrated group which had been castrated at least 12 months (n = 8). Metabolic parameters, blood pressure, and cardiac function using electrocardiography and echocardiography were investigated. We found that although the testosterone level in the castrated group (0.48 ng/mL) was significantly lower than the intact group (5.88 ng/mL) (P < 0.05), metabolic parameters, blood pressure, and cardiac function were not different in the two groups. Castrated dogs did, however, have a higher body condition score than intact dogs. These findings suggest that testosterone deprivation in male dogs can induce obesity but that it does not induce impairment of cardiac function.
Article Details
How to Cite
Boonyapakorn, C., Pinsuwan, T., Chumpuchai, T., & Pongkan, W. (2019). Testosterone deprivation increases tendency to obesity but does not affect cardiac function in dogs. Veterinary Integrative Sciences, 17(3), 245–254. Retrieved from https://he02.tci-thaijo.org/index.php/vis/article/view/211665
Section
Research Articles
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publishing an article with open access in Veterinary Integrative Sciences leaves the copyright with the author. The article is published under the Creative Commons Attribution License 4.0 (CC-BY 4.0), which allows users to read, copy, distribute and make derivative works from the material, as long as the author of the original work is cited.
References
Fogari, R., Preti, P., Zoppi, A., Fogari, E., Rinaldi, A., Corradi L., Mugellini, A., 2005. Serum testosterone levels and arterial blood pressure in the elderly. Hypertens Res, 28, 625-30.
Fogari, R., Zoppi, A., Preti, P., Rinaldi, A., Marasi, G., Vanasia, A., Mugellini, A., 2002. Sexual activity and plasma testosterone levels in hypertensive males. Am J Hypertens, 15, 217-21.
Friedewald, W.T., Levy, R.I., Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. ClinChem, 18, 499-502.
Fulop, L., Banyasz, T., Szabo, G., Toth, I.B., Biro, T., Lorincz, I., Balogh, A., Peto, K., Miko, I., Nanasi, P.P., 2006. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol (Oxf), 188, 163-71.
Heidenberger, E., Unshelm, J., 1990. Changes in the behavior of dogs after castration. TierarztlPrax, 18, 69-75.
Jones, T.H., 2010. Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab, 21, 496-503.
Kaushik, M., Sontineni, S.P., Hunter, C., 2010. Cardiovascular disease and androgens: a review. Int J Cardiol, 142, 8-14.
Kloner, R.A., Carson, C., Dobs, A., Kopecky, S., Mohler, E.R., 2016. Testosterone and cardiovascular disease. J Am Coll Cardiol, 67, 545-57.
Kobayashi, T., Koie, H., Kusumi, A., Kitagawa, M., Kanayama, K., Otsuji, K., 2014. Comparative investigation of body composition in male dogs using CT and body fat analysis software. J Vet Med Sci, 76, 439-46.
Pongkan, W., Chattipakorn, S.C., Chattipakorn, N., 2015. Chronic testosterone replacement exerts cardioprotection against cardiac ischemia-reperfusion injury by attenuating mitochondrial dysfunction in testosterone-deprived rats. PLoS One, 10, e0122503.
Pongkan, W., Pintana, H., Jaiwongkam, T., Kredphoo, S., Sivasinprasasn, S., Chattipakorn, S.C., Chattipakorn N., 2016a. Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats. J Endocrinol, 231, 81-95, 2016a.
Pongkan, W., Pintana, H., Sivasinprasan, S., Jaiwongkam, T., Chattipakorn, N., Chattipakorn, S.C., 2016b. Testosterone deprivation accelerates cardiac dysfunction in obese male rats. J Endocrinol, 229, 209-20.
White, G.A., Hobson-West P., Cobb, K., Craigon, J., Hammond, R., Millar, K.M., 2011. Canine obesity: is there a difference between veterinarian and owner perception? J Small Anim Pract, 52, 622-6.
Fogari, R., Zoppi, A., Preti, P., Rinaldi, A., Marasi, G., Vanasia, A., Mugellini, A., 2002. Sexual activity and plasma testosterone levels in hypertensive males. Am J Hypertens, 15, 217-21.
Friedewald, W.T., Levy, R.I., Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. ClinChem, 18, 499-502.
Fulop, L., Banyasz, T., Szabo, G., Toth, I.B., Biro, T., Lorincz, I., Balogh, A., Peto, K., Miko, I., Nanasi, P.P., 2006. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol (Oxf), 188, 163-71.
Heidenberger, E., Unshelm, J., 1990. Changes in the behavior of dogs after castration. TierarztlPrax, 18, 69-75.
Jones, T.H., 2010. Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab, 21, 496-503.
Kaushik, M., Sontineni, S.P., Hunter, C., 2010. Cardiovascular disease and androgens: a review. Int J Cardiol, 142, 8-14.
Kloner, R.A., Carson, C., Dobs, A., Kopecky, S., Mohler, E.R., 2016. Testosterone and cardiovascular disease. J Am Coll Cardiol, 67, 545-57.
Kobayashi, T., Koie, H., Kusumi, A., Kitagawa, M., Kanayama, K., Otsuji, K., 2014. Comparative investigation of body composition in male dogs using CT and body fat analysis software. J Vet Med Sci, 76, 439-46.
Pongkan, W., Chattipakorn, S.C., Chattipakorn, N., 2015. Chronic testosterone replacement exerts cardioprotection against cardiac ischemia-reperfusion injury by attenuating mitochondrial dysfunction in testosterone-deprived rats. PLoS One, 10, e0122503.
Pongkan, W., Pintana, H., Jaiwongkam, T., Kredphoo, S., Sivasinprasasn, S., Chattipakorn, S.C., Chattipakorn N., 2016a. Vildagliptin reduces cardiac ischemic-reperfusion injury in obese orchiectomized rats. J Endocrinol, 231, 81-95, 2016a.
Pongkan, W., Pintana, H., Sivasinprasan, S., Jaiwongkam, T., Chattipakorn, N., Chattipakorn, S.C., 2016b. Testosterone deprivation accelerates cardiac dysfunction in obese male rats. J Endocrinol, 229, 209-20.
White, G.A., Hobson-West P., Cobb, K., Craigon, J., Hammond, R., Millar, K.M., 2011. Canine obesity: is there a difference between veterinarian and owner perception? J Small Anim Pract, 52, 622-6.